Literature DB >> 7236867

Identification of minor metabolites of 5-fluorocytosine in man by chemical ionization gas chromatography mass spectrometry.

K M Williams, A M Duffield, R K Christopher, P J Finlayson.   

Abstract

A new minor metabolite of 5-fluorocytosine, 5-hydroxy-5-fluorocytosine, was found in the urinary gravel excreted by a patient being treated with this drug. A metabolite of 5-fluorocytosine in animals, alpha-fluoro-beta-alanine, was identified and quantitated in the urine of nine patients. In general, alpha-fluoro-beta-alanine represented 0.05--0.25% of the daily dose of 5-fluorocytosine, both for orally and intravenously administered drug. Minor metabolites have been implicated in the occasional toxicity observed in patients receiving 5-fluorocytosine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236867     DOI: 10.1002/bms.1200080410

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  5 in total

1.  Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora.

Authors:  B E Harris; B W Manning; T W Federle; R B Diasio
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

2.  5-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.

Authors:  T M Kerkering; P M Schwartz; A Espinel-Ingroff; P J Turek; R B Diasio
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

3.  Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopy.

Authors:  M C Malet-Martino; R Martino; M de Forni; A Andremont; O Hartmann; J P Armand
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

4.  Antifungal resistance and new strategies to control fungal infections.

Authors:  Patrick Vandeputte; Selene Ferrari; Alix T Coste
Journal:  Int J Microbiol       Date:  2011-12-01

Review 5.  Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.

Authors:  Angela Loyse; Françoise Dromer; Jeremy Day; Olivier Lortholary; Thomas S Harrison
Journal:  J Antimicrob Chemother       Date:  2013-06-20       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.